How Cost-Effective Is the Treatment of Dyslipidemia in Patients With Diabetes but Without Cardiovascular Disease?
Article Information
vol. 24 no. 1 45-50
PubMed
Published By
Print ISSN
Online ISSN
History
- September 28, 2000
- April 11, 2000
- Published in print January 1, 2001.
Copyright & Usage
by the American Diabetes Association,
Inc.
Author Information
- Steven A. Grover, MD, MPA, FRCPC,
- Louis Coupal, MSC,
- Hanna Zowall, MSC,
- Charles M. Alexander, MD, FACP, FACE,
- Thomas W. Weiss, DRPH and
- Daniel R.J. Gomes, MSC
- From the Centre for the Analysis of Cost-Effective Care and the Divisions of General Internal Medicine and Clinical Epidemiology (S.A.G., L.C., H.Z.), the Montreal General Hospital; the Department of Medicine and the Department of Epidemiology and Biostatistics (S.A.G.), McGill University, Montreal, Quebec, Canada; and Merck & Co. (T.W.W., D.R.J.G., C.M.A.), Whitehouse Station, New Jersey and West Point, Pennsylvania.
- Address correspondence and reprint requests to Steven A. Grover, MD, MPA, FRCPC, Division of Clinical Epidemiology, The Montreal General Hospital, 1650 Cedar Ave., Montreal, PQ H3G 1A4, Canada. E-mail: mdev{at}musica.mcgill.ca .